Corcept Therapeutics Incorporated (CORT) — Quality & forensics
As of 2026-10-15 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 22
- Quality 48
- Growth 60
- Balance sheet 90
- Cash quality 54
- Capital allocation 35
- Momentum 92
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the CORT chart & overview · the earnings record
FAQ · from the current data · as of 2026-10-15
Quick answers
What is Corcept Therapeutics Incorporated's Closelooknet quality reading?
The composite reads 57/100 across 7 modules, as of 2026-10-15: valuation 22, quality 48, growth 60, balance sheet 90, cash quality 54, capital allocation 35, momentum 92. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Corcept Therapeutics Incorporated's Altman Z-Score?
44.24, which sits in the safe zone (above 2.99) as of 2026-10-15. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Corcept Therapeutics Incorporated's Piotroski F-Score?
4 of 8, as of 2026-10-15. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Corcept Therapeutics Incorporated's Beneish M-Score indicate?
-2.75 — below the −1.78 manipulation-risk threshold, as of 2026-10-15. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Mentioned on Closelooknet
Where CORT appears in the diary — 1 piece, newest first. Every link is our own writing.
Go deeper
Dailies
- A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000
Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG…
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- ARGX argenx NV ADRindustry
- UCB.BR UCB SAindustry
- KRYS Krystal Biotech Incindustry
- MRNA Moderna Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- CAI Caris Life Sciences, Inc. Common Stockindustry
- RXRX Recursion Pharmaceuticals Incindustry
- EXEL Exelixis Incindustry
- RPRX Royalty Pharma Plcindustry
- TECH Bio-Techne Corpindustry
- MRVI Maravai Lifesciences Holdings Incindustry
- TWST Twist Bioscience Corpindustry
- BION.SW BB Biotech AGindustry
- INCY Incyte Corporationindustry
- JAZZ Jazz Pharmaceuticals PLCindustry
- GNS.L Genus PLCindustry